You are here Home Guidance and resources Maxx Pharma Pty Ltd Regulatory activities for this sponsor. Listen Print Share Loading... Type Prescription medicine registration (3) (-) Prescription medicine registration (3) ARTG (16) ARTG (16) Cancellation by sponsor (6) Cancellation by sponsor (6) Australian Public Assessment Report (AusPAR) (3) Australian Public Assessment Report (AusPAR) (3) Prescription medicine decision summary (3) Prescription medicine decision summary (3) Designation or determination (2) Designation or determination (2) Show more Date 2022 (1) 2022 (1) 2021 (1) 2021 (1) 2020 (1) 2020 (1) Search Filters applied:Prescription medicine registrationClear all Sponsor content3 result(s) found, displaying 1 to 3 VAXELIS (Maxx Pharma Pty Ltd) 22 March 2022 Prescription medicine registration Active ingredients: DTPa5-HB-IPV-Hib. ZEBINIX (Maxx Pharma Pty Ltd) 10 May 2021 Prescription medicine registration Active ingredients: eslicarbazepine acetate. ONGENTYS (Maxx Pharma Pty Ltd) 18 September 2020 Prescription medicine registration Active ingredients: opicapone.
VAXELIS (Maxx Pharma Pty Ltd) 22 March 2022 Prescription medicine registration Active ingredients: DTPa5-HB-IPV-Hib.
ZEBINIX (Maxx Pharma Pty Ltd) 10 May 2021 Prescription medicine registration Active ingredients: eslicarbazepine acetate.
ONGENTYS (Maxx Pharma Pty Ltd) 18 September 2020 Prescription medicine registration Active ingredients: opicapone.